Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001393905-12-000384
Filing Date
2012-07-18
Accepted
2012-07-18 17:14:33
Documents
9
Period of Report
2012-02-29

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #1 TO ANNUAL REPORT trab_10ka.htm 10-K/A 496331
2 CERTIFICATION trab_ex311.htm EX-31.1 7759
3 CERTIFICATION trab_ex321.htm EX-32.1 4335
  Complete submission text file 0001393905-12-000384.txt   1968317

Data Files

Seq Description Document Type Size
4 trab-20120229.xml EX-101.INS 208256
5 trab-20120229.xsd EX-101.SCH 12066
6 trab-20120229_cal.xml EX-101.CAL 5740
7 trab-20120229_def.xml EX-101.DEF 67733
8 trab-20120229_lab.xml EX-101.LAB 108701
9 trab-20120229_pre.xml EX-101.PRE 80734
Mailing Address 120 WALL STREET SUITE 2401 NEW YORK NY 10005
Business Address 120 WALL STREET SUITE 2401 NEW YORK NY 10005 866-284-9561
TheraBiogen, Inc. (Filer) CIK: 0001405286 (see all company filings)

EIN.: 980559606 | State of Incorp.: NV | Fiscal Year End: 0228
Type: 10-K/A | Act: 34 | File No.: 000-53008 | Film No.: 12968516
SIC: 2834 Pharmaceutical Preparations